Abstract
Survival rate and causes of death according to the period of diagnosis and four accompanying organ disorders were analyzed in 306 Japanese patients with systemic lupus erythematosus. The survival rate was gradually improved, and the survival rate during 5- and 10-year periods of the patients diagnosed in 1990–2004 was 94 and 92%, 20-year period of those in 1980–1989 was 77%, 30-year period of those in 1975–1979 was 71%, respectively. Survival rate of those with serositis, pulmonary hypertension, and positive family history tended to be reduced, while that of the cases with neuropsychiatric disorder and renal disorder was significantly reduced. Overlapping of these organ disorders was an important factor for a poor prognosis. Bronchopneumonia and cerebrovascular accidents were frequent causes of death, and treatment for anti-phospholipid antibody syndrome and life-style diseases such as hypertension and arteriosclerosis was thought to be important for a good outcome.
Similar content being viewed by others
References
Urowitz MB, Gladman DD, Abu-Shakra M, Farewell VT (1997) Mortality studies in systemic lupus erythematosus. Results from a single center. III. Improved survival over 24 years. J Rheumatol 24:1061–1065
Mok CC, Mak A, Chu WP, To CH, Wong SN (2005) Long-term survival of southern Chinese patients with systemic lupus erythematosus: a prospective study of all age-groups. Medicine (Baltimore) 84:218–224
Kataoka H, Koike T (2004) Lupus mortality in Japan. Autoimmun Rev 3:421–422
Kaslow RA, Masi AT (1978) Age, sex, and race effects on mortality from systemic lupus erythematosus in the United States. Arthritis Rheum 21:473–479
Jönsen A, Bengtsson A, Nived O, Ryberg B, Sturfelt G (2002) Outcome of neuropsychiatric systemic lupus erythematosus within a defined Swedish population: increased morbidity but low mortality. Rheumatology 41:1308–1312
Swaak AJG, van den Brink HG, Smeenk RJ, Manger K, Kalden JR, Tosi S, Marchesoni A, Domljan Z, Rozman B, Logar D, Pokorny G, Kovacs L, Kovacs A, Vlachoyiannnopoulos PG, Moutsopoulos HM, Chwalinska-Sadowska H, Dratwianka B, Kiss E, Cikes N, Branimir A, Schneider M, Fischer R, Bombardieri S, Mosca M, Smolen JS (1999) Systemic lupus erythematosus: clinical features in patients with a disease duration of over 10 years, first evaluation. Rheumatology 38:953–958
Miettunen PM, Ortiz-Alvarez O, Petty RE, Cimaz R, Malleson PN, Cabral DA, Ensworth S, Tucker LB (2004) Gender and ethnic origin have no effect on longterm outcome of childhood-onset systemic lupus erythematosus. J Rheumatol 31:1650–1651
Manger K, Manger B, Repp R, Geisselbreacht M, Geiger A, Pfahlberg A, Harrer T, Kalden JR (2002) Definition of risk factors for death, end stage renal disease, and thrombotic events in a monocentric cohort of 338 patients with systemic lupus erythematosus. Ann Rheum Dis 61:1065–1070
Nived O, Jonsen A, Bengtsson AA, Bengtsson C, Stunfelt G (2002) High predictive value of the systemic lupus International Collaborators Clinics/American College of Rheumatology damage index for survival in systemic lupus erythematosus. J Rheumatol 29:1398–1400
Gladman DD, Urowitz MB, Rahman P, Ibanez D, Tam LS (2003) Accrual of organ damage over time in patients with systemic lupus erythematosus. J Rheumatol 30:1955–1959
Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277
Zar JH (1984) Biostatistical analysis. Prentice-HaIl, Englewood Cliffs, NJ
Boumpas DT, Fessler BJ, Austin HA 3rd, Balow JE, Klippel JH, Lockshin MD (1995) Systemic lupus erythematosus: emerging concepts. Part 2: dermatologic and joint disease, the antiphospholipid antibody syndrome, pregnancy and hormonal therapy, morbidity and mortality, and pathogenesis. Ann Intern Med 123:42–53
Johnson SR, Gladman DD, Urowitz MB, Ibanez D, Granton JT (2004) Pulmonary hypertension in systemic lupus. Lupus 13:506–509
Winslow TM, Ossipov MA, Fazio GP, Simonson JS, Redberg RF, Schiller NB (1995) Five-year follow-up study of the prevalence and progression of pulmonary hypertension in systemic lupus erythematosus. Am Heart J 129:510–515
Kasukawa R, Nishimaki T, Takagi T, Miyawaki S, Yokohari R, Tsunematsu T (1990) Pulmonary hypertension in connective tissue disease. Clinical analysis of sixty patients in multi-institutional study. Clin Rheumatol 9:56–62
Simonson JS, Schiller NB, Petri M, Hellmann DB (1989) Pulmonary hypertension in systemic lupus erythematosus. J Rheumatol 16:918–925
Asherson RA, Higenbottam TW, Dinh Xuan AT, Khamashta MA, Hughes GR (1990) Pulmonary hypertension in a lupus clinic: experience with twenty-four patients. J Rheumatol 17:1292–1298
Gonzalez-Crespo MR, Lopez-Fernandez JI, Usera G, Poveda MJ, Gomez-Reino JJ (1996) Outcome of silent lupus nephritis. Semin Arthritis Rheum 26:468–476
Abu-Shakra M, Urowits MB, Gladman DD, Gough J (1995) Mortality studied in systemic lupus erythematosus. Results from a single study. I. Causes of death. J Rheumatol 22:1259–1264
Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, Mejia JC, Aydintug AO, Chwalinska-Sadowska H, de Ramon E, Fernadez-Nebro A, Galeazzi M, Valen M, Mathieu A, Houssiau F, Caro N, Alba P, Ramos-Casals M, Ingelmo M, Hughes GR, European Working Party on Systemic Lupus Erythematosus (2003) Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestation in a cohort of 1,000 patients. Medicine (Baltimore) 82:299–308
Moroni G, Quaglini S, Maccario M, Banfi G, Ponticelli C (1996) “Nephritis flares” are predictors of bad long-term renal outcome in lupus nephritis. Kidney Int 50:2047–2053
Worrall JG, Snaith ML, Batchelor JR, Isenberg DA (1990) SLE: a rheumatological view. Analysis of the clinical features, serology and immunogenetics of 100 SLE patients during long-term follow-up. QJM 74:319–330
Zampieri S, Iaccarino L, Ghirardello A, Tarricone E, Arienti S, Sarzi-Puttini, Gambari P, Doria A (2005) Systemic lupus erythematosus, atherosclerosis, and autoantibodies. Ann NY Acad Sci 1051:351–361
Font J, Ramos-Casals M, Cervera R, Garcia-Carrasco M, Torras A, Siso A, Darnell A, Ingelmo M (2001) Cardiovascular risk factors and the long-term outcome of lupus nephritis. QJM 94:19–26
Bijornadal L, Yin L, Granath F, Klareskog L, Ekbom A (2004) Cardiovascular disease a hazard despite improved prognosis in patients with systemic lupus erythematosus: results from a Swedish population based study 1964–95. J Rheumatol 31:713–719
Ward MM, Pyun E, Studenski S (1995) Causes of death in systemic lupus erythematosus. Long-term follow-up of an inception cohort. Arthritis Rheum 38:1492–1499
Alarcon-Segovia D, Perez-Ruiz A, villa AR (2000) Long-term prognosis of anti-phospholipid syndrome in patients with systemic lupus erythematosus. J Autoimmun 15:157–161
Sthoeger ZM, Geltner D, Rider A, Bentwich Z (1987) Systemic lupus erythematosus in 49 Israeli males: a retrospective study. Clin Exp Rheumatol 5:233–240
Tyndall A, Saccardi R (2005) Haematopoietic stem cell transplantation in the treatment of severe autoimmune disease: results from phase I/II studies, prospective randomized trials and future directions. Clin Exp Immunol 141:1–9
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Funauchi, M., Shimadzu, H., Tamaki, C. et al. Survival study by organ disorders in 306 Japanese patients with systemic lupus erythematosus: results from a single center. Rheumatol Int 27, 243–249 (2007). https://doi.org/10.1007/s00296-006-0201-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-006-0201-9